Table 2 Treatment characteristics

Neoadjuvant chemotherapy

 platinum

  cisplatin

67(82%)

  carboplatin

15(18%)

 second agent

  gemcitabine

45(55%)

  paclitaxel

29(35%)

  pemetrexed

8(10%)

Treatment cycles

  2

77(94%)

  3

3(4%)

  >3

2(2%)

Type of resection

  pneumonectomy

16(20%)

  lobectomy

52(63%)

  bilobectomy

8(10%)

  wedge resections

2(2%)

  exploration

4(5%)

Completeness of resection

  R0

76(93%)

  R1

1(1%)

  R2

5(6%)

Cell type after operation

 squamous

51(62%)

 adenocarcinoma

29(35%)

 large cell

2(3%)